drugset / Trial / NCT07619157

A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus

NCT07619157 ↗

Phase 1 Recruiting 120 enrolled Ono Pharmaceutical Co., Ltd.
Non-randomizedSequentialOpen-labelTreatment

Summary

To investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of ONO-3310 in healthy Japanese adult male subjects and chronic kidney disease patients with type 2 diabetes mellitus

Timeline

Start
2026-06-02
Primary completion
2027-11-30
Completion
2027-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ONO-3310 Unknown — Oral